Additionally, a purinergic receptor (ADORA1) has been previously implicated in asthma susceptibility by genome wide association studies (GWAS) and by functional studies (17), thereby further supporting the potential for purinergic receptors as therapeutic targets for asthma. This evidence concerns the gene P2RX2 and asthma.